IP Library Granted Patent US 9,791,447
Granted Patent B2
US 9,791,447 · App. 14/247,153 · Granted Oct 17, 2017

Methods of identifying SENP1 inhibitors

Inventor: Yuan Chen (Arcadia, CA)
Assignee: City of Hope
G01N33/573G01N2440/36G01N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,791,447
App. No.
14/247,153
Granted
Oct 17, 2017
Kind
B2
Abstract

Provided herein are methods of detecting binding of an SENP1 polypeptide to a compound and methods for screening for inhibitors of SENP1. Further provided are aqueous compositions comprising SENP1 polypeptides and NMR apparatuses comprising the compositions for NMR analysis.

Claims (14)

1. A method of detecting binding of an SENP1 polypeptide to a compound, the method comprising:

(i) contacting an SENP1-SUMO complex with a compound, wherein the SENP1-SUMO complex comprises an SENP1 polypeptide and a SUMO protein;

(ii) allowing the compound to bind to the SENP1 polypeptide of the SENP1-SUMO complex, thereby forming a SENP1-SUMO-compound complex;

(iii) detecting the SENP1-SUMO-compound complex using nuclear magnetic resonance, thereby detecting binding of the SENP1 polypeptide to the compound.

2. The method of claim 1 , wherein the detecting comprises

determining a chemical shift for an amino acid in an active site of the SENP1 polypeptide.

3. The method of claim 2 , wherein the chemical shift in the presence of the compound is changed relative to the corresponding chemical shift in the absence of the compound.

4. The method of claim 3 , wherein the amino acid is selected from the group consisting of an amino acid residue corresponding to D550, H533, C603, W465, W534, L466, G531, C535, M552, G554, E469 and Q596 of SEQ ID NO: 1.

5. The method of claim 1 , wherein the SENP1 polypeptide comprises SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.

6. The method of claim 1 , wherein the SENP1 polypeptide comprises a mutation at amino acid residue corresponding to amino acid residue 603 of SEQ ID NO: 1.

7. The method of claim 1 , wherein the detecting comprises producing an NMR spectra of the SENP1-SUMO-compound complex and identifying a change in the NMR spectra relative to the absence of the compound.

8. The method of claim 7 , wherein the change is a change in the chemical shift of an amino acid of SEQ ID NOs: 3, 4, 5, 6 or 7.

9. The method of claim 7 , wherein the change is a change in the chemical shift of the amino acid 5603.

10. The method of claim 7 , wherein the change is a change in the chemical shift of an amino acid residue 440-455, 463-473, 493-515, 529-535, 550-554, or 596-603 of SEQ ID NO: 1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: NAMANJA, ANDREW; CHEN, YUAN; CHEN, CHIH-HONG
To: CITY OF HOPE
Reel/Frame 056277/0723 →
CONFIRMATORY LICENSE Recorded Oct 23, 2015
From: CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036943/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: CHEN, YUAN
To: CITY OF HOPE
Reel/Frame 034176/0383 →
Continuity (3)
Provisional Application 61809208 · Apr 5, 2013
Provisional Application 61813832 · Apr 19, 2013
Related Publication 20140302525A1 · Oct 9, 2014